To externally validate the STAR-CAP prognostic system for prostate cancer (PCa) and compare it to the CAPRA score to predict for biochemical recurrence (BCR) after radiation therapy (RTx). We included patients treated with RTx between 2002 and 2021 for non-metastatic PCa at our institution.
Efforts are ongoing to try and find ways to reduce the number of unnecessary prostate biopsies without missing clinically significant prostate cancers (csPCa). The utility of multiparametric magnetic resonance imaging (mpMRI) in detecting prostate cancer (PCa) shows promise to be used as triage test for systematic prostate biopsy.
Genetic counseling and germline testing have an increasingly important role for patients with prostate cancer (PCa); however, recent data suggests they are underutilized. Our objective was to perform a qualitative study of the barriers and facilitators of germline genetic evaluation among physicians who manage PCa.
We hypothesized that Gleason Grade Group (GGG) IV patients treated with radical prostatectomy (RP) or external beam radiotherapy (EBRT) exhibit different cancer-specific mortality (CSM) rates according to underlying Gleason patterns (GP): 4 + 4 versus 3 + 5 versus 5 + 3.
To examine the effect of lymph node dissection on the outcomes of patients who underwent salvage radical prostatectomy (SRP). We retrospectively reviewed data from radiation-recurrent patients with prostate cancer (PCa) who underwent SRP from 2000-2016.
To assess both short- and long-term constipation symptoms and their impact on quality of life in patients who underwent radical cystectomy (RC) with three different types of urinary diversion: orthotopic neobladder (ONB), continent cutaneous diversion (CCD), and ileal conduit (IC).
Smoking has a strong causal association with bladder cancer but the relationship with recurrence is not well established. We sought to assess the association of smoking status on recurrence of non-muscle invasive bladder cancer (NMIBC) in a contemporary cohort of patients with predominantly high-risk, recurrent NMIBC managed with photodynamic enhanced cystoscopy.
Advanced penile SCC (PSCC) is a rare diagnosis and carries a grim prognosis as patients who experience distant metastases are unlikely to live more than two years. There is very limited evidence to guide systemic treatment of advanced PSCC. Standard first-line treatment of advanced PSCC is paclitaxel, ifosfamide, and cisplatin (TIP). Optimal second-line or later […]
It is my hypothesis that the trigone, and only the trigone, should be the site of botulinum toxin A (BTA) injection for the treatment of refractory OAB, and the results of this case series1 reinforce this view.
～Strategic Acquisition to Expand its BPH Portfolio into In-office Treatment～ San Francisco, CA (UroToday.com) — Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President, and CEO: Yasuo Takeuchi) announced that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik) following the announcement of its decision to exercise the […]
